Val66Met polymorphism and serum brain‐derived neurotrophic factor in bipolar disorder: an open‐label trial
Article 2013 en
Authors
IG
Iría Grande
PM
Pedro Vieira da Silva Magalhães
IC
Inês Chendo
Abstract
1 min read
This study provides the first longitudinal evidence that both the BDNF Val66Met polymorphism and remission status predict change in circulating BDNF levels.
Iría Grande, Inês Chendo, Benício N. Frey, Keila M. Ceresér, Laura Stertz, Gabriela Delevati Colpo, GR Fries, Angelo Batista da Cunha, Eduard Vieta, Flávio Kapczinski
Hilga Katerberg, Christine Löchner, Daniëlle C. Cath, Peter de Jonge, Zoltán Bochdanovits, Johanna C. Moolman‐Smook, Sian Hemmings, Paul D. Carey, Dan Joseph Stein, David Sondervan, Johan A. den Boer, Anton J.L.M. van Balkom, Annemiek Polman, Peter Heutink
Daphne Margoni, Kelly Michalakakou, Eleni Angeli, Panagiota Pervanidou, Christina Kanaka‐Gantenbein, George Chrousos, Ioannis Papassotiriou, Elefthería Roma
Discussion(0)
No comments yet. Be the first to comment.